Hypha Labs, Inc.

Hypha Labs, Inc.

Diagnostics & Research Healthcare Las Vegas, NV, United States FUNI (OQB)

Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Diagnostics & Research Companies

View All →

Frequently Asked Questions

Has Hypha Labs, Inc. had layoffs?
No layoff events have been recorded for Hypha Labs, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Hypha Labs, Inc. in?
Hypha Labs, Inc. operates in the Diagnostics & Research industry, within the Healthcare sector.
Is Hypha Labs, Inc. a publicly traded company?
Yes, Hypha Labs, Inc. is publicly traded under the ticker symbol FUNI on the OQB. The company has a market capitalization of approximately $0.01 billion.
Where is Hypha Labs, Inc. headquartered?
Hypha Labs, Inc. is headquartered in Las Vegas, NV, United States at 5940 S. Rainbow Boulevard, Las Vegas, NV 89118, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.